Table of Contents

company-logo

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.

Seelos Therapeutics Dividend Announcement

• Seelos Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Seelos Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Seelos Therapeutics Dividend History

Seelos Therapeutics Dividend Yield

Seelos Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Seelos Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Seelos Therapeutics Financial Ratios

P/E ratio0.45
PEG ratio-0.16
P/B ratio-0.07
ROE-13.07%
Payout ratio0.00%
Current ratio0.08
Quick ratio0.08
Cash Ratio0.01

Seelos Therapeutics Dividend FAQ

Does Seelos Therapeutics stock pay dividends?
Seelos Therapeutics does not currently pay dividends to its shareholders.
Has Seelos Therapeutics ever paid a dividend?
No, Seelos Therapeutics has no a history of paying dividends to its shareholders. Seelos Therapeutics is not known for its dividend payments.
Why doesn't Seelos Therapeutics pay dividends?
There are several potential reasons why Seelos Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Seelos Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Seelos Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Seelos Therapeutics a dividend aristocrat?
Seelos Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Seelos Therapeutics a dividend king?
Seelos Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Seelos Therapeutics a dividend stock?
No, Seelos Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Seelos Therapeutics stocks?
To buy Seelos Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Seelos Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.